Chinese biotech GenScript surges as it rebuffs US lawmakers’ allegations

The Hong Kong-listed biotech company rose as much as 29 per cent after rejecting suggestions it poses a national security risk

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.